Porphyromonas gingivalis fuels colorectal cancer through CHI3L1-mediated iNKT cell-driven immune evasion

Gut Microbes. 2024 Jan-Dec;16(1):2388801. doi: 10.1080/19490976.2024.2388801. Epub 2024 Aug 12.

Abstract

The interaction between the gut microbiota and invariant Natural Killer T (iNKT) cells plays a pivotal role in colorectal cancer (CRC). The pathobiont Fusobacterium nucleatum influences the anti-tumor functions of CRC-infiltrating iNKT cells. However, the impact of other bacteria associated with CRC, like Porphyromonas gingivalis, on their activation status remains unexplored. In this study, we demonstrate that mucosa-associated P. gingivalis induces a protumour phenotype in iNKT cells, subsequently influencing the composition of mononuclear-phagocyte cells within the tumor microenvironment. Mechanistically, in vivo and in vitro experiments showed that P. gingivalis reduces the cytotoxic functions of iNKT cells, hampering the iNKT cell lytic machinery through increased expression of chitinase 3-like-1 protein (CHI3L1). Neutralization of CHI3L1 effectively restores iNKT cell cytotoxic functions suggesting a therapeutic potential to reactivate iNKT cell-mediated antitumour immunity. In conclusion, our data demonstrate how P. gingivalis accelerates CRC progression by inducing the upregulation of CHI3L1 in iNKT cells, thus impairing their cytotoxic functions and promoting host tumor immune evasion.

Keywords: CHI3L1; CRC; Porphyromonas gingivalis; iNKT cells.

MeSH terms

  • Animals
  • Bacteroidaceae Infections / immunology
  • Bacteroidaceae Infections / microbiology
  • Cell Line, Tumor
  • Chitinase-3-Like Protein 1* / genetics
  • Chitinase-3-Like Protein 1* / metabolism
  • Colorectal Neoplasms* / immunology
  • Colorectal Neoplasms* / microbiology
  • Female
  • Gastrointestinal Microbiome / immunology
  • Humans
  • Immune Evasion
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Natural Killer T-Cells* / immunology
  • Porphyromonas gingivalis* / immunology
  • Tumor Escape
  • Tumor Microenvironment / immunology

Substances

  • Chitinase-3-Like Protein 1
  • CHI3L1 protein, human

Grants and funding

This work was made possible thanks to the financial support of Associazione Italiana per la Ricerca sul Cancro [Start-Up 2013 14378, Investigator Grant - IG 2019 22923 to FF] and of Italy’s Ministry of Health [GR-2016-0236174 to FF and FC]. This work has received funding from the European Union - NextGenerationEU through the Italian Ministry of University and Research under the PNRR - M4C2-I1.3 Project PE_00000019 “HEAL ITALIA” to FF. This work has been and partially supported by the Italian Ministry of Health with Ricerca Corrente and 5 × 1000fund.